Primary malignant neoplasm of ovary and other uterine adnexa
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
6
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hyperlipidemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
472
|
83
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Thrombosis of cerebral veins
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
35
|
11
|
0.110 |
None |
1.000 |
1 |
|
1980 |
1980 |
Portal Vein Thrombosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
59
|
8
|
0.110 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hepatic Vein Thrombosis
|
disease |
Digestive System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
23
|
4
|
0.110 |
None |
1.000 |
1 |
|
2001 |
2001 |
Thrombophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
161
|
43
|
0.100 |
None |
1.000 |
13 |
|
1992 |
2017 |
Activated Protein C Resistance
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
41
|
30
|
0.100 |
None |
1.000 |
12 |
|
1996 |
2015 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Mesenteric Venous Thrombosis
|
phenotype |
Digestive System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Retinal Vein Occlusion
|
disease |
Eye Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
76
|
15
|
0.100 |
None |
|
0 |
|
|
|
Superficial Thrombophlebitis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Pulmonary Embolism
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Pathologic Function
|
93
|
16
|
0.100 |
None |
|
0 |
|
|
|
Arterial thrombosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
33
|
1
|
0.100 |
None |
|
0 |
|
|
|
Occlusion of artery (disorder)
|
phenotype |
|
Pathologic Function
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Superficial Thrombophlebitis, CTCAE
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Reduced antithrombin antigen
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent spontaneous abortion
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent thrombophlebitis
|
phenotype |
Cardiovascular Diseases
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Portal Vein Thrombosis, CTCAE
|
phenotype |
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Factor V Leiden mutation
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
46
|
0.090 |
None |
0.889 |
9 |
|
1997 |
2016 |
Lupus anticoagulant disorder
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
66
|
14
|
0.090 |
None |
1.000 |
9 |
|
1994 |
2012 |
Protein S Deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
19
|
14
|
0.070 |
None |
1.000 |
7 |
|
1988 |
2012 |
Kidney Failure, Acute
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
826
|
32
|
0.050 |
None |
1.000 |
5 |
|
2015 |
2019 |